KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Analyst Ratings
NASDAQ:KMTS - Nasdaq - BMG524411052 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to KMTS. The Buy consensus is the weighted average rating of the current analysts ratings.
KMTS was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KMTS.
In the previous month the buy percentage consensus was at a similar level.
KMTS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-16 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-31 | Wolfe Research | Initiate | Outperform |
| 2025-03-31 | Stifel | Initiate | Buy |
| 2025-03-31 | Wells Fargo | Initiate | Overweight |
| 2025-03-31 | Goldman Sachs | Initiate | Neutral |
| 2025-03-31 | Piper Sandler | Initiate | Overweight |